As of 2026-04-08, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (2.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.27 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -112.0%.
The range of the Relative Valuation is (2.57) - (2.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 24.6x | 22.0x |
| Forward P/E multiples | 19.8x - 22.5x | 21.0x |
| Fair Price | (2.57) - (2.93) | (2.80) |
| Upside | -111.1% - -112.6% | -112.0% |
| Date | P/E |
| 2026-04-07 | -178.81 |
| 2026-04-06 | -181.77 |
| 2026-04-02 | -181.58 |
| 2026-04-01 | -185.19 |
| 2026-03-31 | -181.04 |
| 2026-03-30 | -163.90 |
| 2026-03-27 | -163.06 |
| 2026-03-26 | -171.97 |
| 2026-03-25 | -174.74 |
| 2026-03-24 | -167.75 |
| 2026-03-23 | -171.28 |
| 2026-03-20 | -170.67 |
| 2026-03-19 | -176.04 |
| 2026-03-18 | -170.90 |
| 2026-03-17 | -174.58 |
| 2026-03-16 | -174.89 |
| 2026-03-13 | -174.81 |
| 2026-03-12 | -176.04 |
| 2026-03-11 | -184.04 |
| 2026-03-10 | -188.95 |
| 2026-03-09 | -190.72 |
| 2026-03-06 | -184.42 |
| 2026-03-05 | -184.19 |
| 2026-03-04 | -185.34 |
| 2026-03-03 | -181.35 |
| 2026-03-02 | -190.26 |
| 2026-02-27 | -207.24 |
| 2026-02-26 | -219.54 |
| 2026-02-25 | -207.55 |
| 2026-02-24 | -207.32 |
| 2026-02-23 | -202.17 |
| 2026-02-20 | -195.29 |
| 2026-02-19 | -214.77 |
| 2026-02-18 | -205.24 |
| 2026-02-17 | -204.48 |
| 2026-02-13 | -198.71 |
| 2026-02-12 | -205.24 |
| 2026-02-11 | -204.32 |
| 2026-02-10 | -206.55 |
| 2026-02-09 | -206.55 |
| 2026-02-06 | -209.93 |
| 2026-02-05 | -200.33 |
| 2026-02-04 | -200.40 |
| 2026-02-03 | -201.25 |
| 2026-02-02 | -196.48 |
| 2026-01-30 | -194.95 |
| 2026-01-29 | -197.71 |
| 2026-01-28 | -195.56 |
| 2026-01-27 | -202.32 |
| 2026-01-26 | -202.25 |